Karyopharm Therapeutics Stock (NASDAQ: KPTI) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 1.00 / 1.43M |
Day Range | - - - |
52 Wk Range | 0.62 - 1.95 |
Market Cap | $112.28M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 46 |
Short Interest | 17.71% |
Days to Cover | 8.55 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Karyopharm Therapeutics (NASDAQ:KPTI) through any online brokerage.
Other companies in Karyopharm Therapeutics’s space includes: CytomX Therapeutics (NASDAQ:CTMX), Armata Pharmaceuticals (AMEX:ARMP), FibroGen (NASDAQ:FGEN), Vistagen Therapeutics (NASDAQ:VTGN) and Adicet Bio (NASDAQ:ACET).
There is no analysis for Karyopharm Therapeutics.
Karyopharm Therapeutics has a consensus price target of $8.64.
The stock price for Karyopharm Therapeutics (NASDAQ: KPTI) is $0.901 last updated July 19, 2024 at 6:54 PM EDT.
There are no upcoming dividends for Karyopharm Therapeutics.
Karyopharm Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Karyopharm Therapeutics.
Karyopharm Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.